Showing results (721-730 of 3,150) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|January 9, 2025
A Hitchhiker's Guide Toward CSF Biomarkers for Neuro-OncologyCecile Riviere-Cazaux, Michael B Keough, Jeffrey A Zuccato, et al.
Neuro-Oncology|December 19, 2024
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trialKarsten Nysom, Lindsay B Kilburn, Sarah E S Leary, et al.
Neuro-Oncology|February 3, 2025
Molecular subtypes of adamantinomatous craniopharyngiomasWenhao An, Shouwei Li, Yihua An, et al.
Neuro-Oncology|December 10, 2024
The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastomaMatthew McCord, Thomas Sears, Wenxia Wang, et al.
Neuro-Oncology|December 22, 2023
Management of sporadic intracanalicular vestibular schwannomas: A critical review and International Stereotactic Radiosurgery Society (ISRS) practice guidelinesAnne Balossier, Arjun Sahgal, Rupesh Kotecha, et al.
Neuro-Oncology|December 22, 2023
The ERK inhibitor LY3214996 augments anti-PD-1 immunotherapy in preclinical mouse models of BRAFV600E melanoma brain metastasisMagali A de Sauvage, Consuelo Torrini, Edwin Nieblas-Bedolla, et al.
Neuro-Oncology|December 9, 2023
Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastomaYanfei Sun, Guangjing Mu, Xuehai Zhang, et al.
Neuro-Oncology|January 3, 2024
Automated segmentation of ablated lesions using deep convolutional neural networks: A basis for response assessment following laser interstitial thermal therapyAden P Haskell-Mendoza, Ellery H Reason, Ariel T Gonzalez, et al.
Neuro-Oncology|December 1, 2023
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 studyJacoline E C Bromberg, Samar Issa, Bronno van der Holt, et al.
Neuro-Oncology|November 27, 2023
Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201Dazhuan Eric Xin, Yunfei Liao, Rohit Rao, et al.
Pageof 315